2Seventy Historical Income Statement

TSVT Stock  USD 3.65  0.13  3.44%   
Historical analysis of 2Seventy Bio income statement accounts such as Selling General Administrative of 86.4 M, Total Revenue of 108.8 M, Gross Profit of 98.7 M or Other Operating Expenses of 226.9 M can show how well 2Seventy Bio performed in making a profits. Evaluating 2Seventy Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of 2Seventy Bio's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining 2Seventy Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether 2Seventy Bio is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.

About 2Seventy Income Statement Analysis

2Seventy Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to 2Seventy Bio shareholders. The income statement also shows 2Seventy investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

2Seventy Bio Income Statement Chart

At this time, 2Seventy Bio's Net Interest Income is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 10.7 M in 2024, whereas Operating Income is likely to drop (227.5 M) in 2024.

Total Revenue

Total revenue comprises all receipts 2Seventy Bio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of 2Seventy Bio minus its cost of goods sold. It is profit before 2Seventy Bio operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of 2Seventy Bio. It is also known as 2Seventy Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from 2Seventy Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into 2Seventy Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.At this time, 2Seventy Bio's Net Interest Income is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 10.7 M in 2024, whereas Operating Income is likely to drop (227.5 M) in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit52.0M65.3M83.5M98.7M
Total Revenue54.5M91.5M100.4M108.8M

2Seventy Bio income statement Correlations

-0.380.150.870.490.390.13-0.39-0.18-0.550.59-0.190.730.87-0.57-0.370.15-0.41-0.29-0.79
-0.380.580.05-0.32-0.24-0.42-0.45-0.55-0.330.310.41-0.610.030.89-0.360.64-0.39-0.540.79
0.150.580.41-0.17-0.16-0.85-0.5-0.46-0.410.220.78-0.120.280.63-0.440.99-0.45-0.990.15
0.870.050.410.570.52-0.02-0.47-0.28-0.590.810.070.490.98-0.13-0.380.45-0.44-0.54-0.44
0.49-0.32-0.170.570.990.420.420.570.270.530.070.330.58-0.260.52-0.110.450.1-0.25
0.39-0.24-0.160.520.990.390.470.610.330.510.120.190.53-0.170.57-0.090.50.1-0.12
0.13-0.42-0.85-0.020.420.390.260.270.120.29-0.790.340.1-0.580.27-0.80.230.78-0.19
-0.39-0.45-0.5-0.470.420.470.260.970.98-0.460.15-0.2-0.47-0.120.99-0.51.00.580.14
-0.18-0.55-0.46-0.280.570.610.270.970.92-0.350.15-0.09-0.28-0.250.97-0.470.960.51-0.01
-0.55-0.33-0.41-0.590.270.330.120.980.92-0.570.25-0.34-0.610.030.96-0.420.980.510.28
0.590.310.220.810.530.510.29-0.46-0.35-0.57-0.090.310.840.04-0.330.31-0.42-0.34-0.07
-0.190.410.780.070.070.12-0.790.150.150.25-0.09-0.36-0.070.70.210.770.21-0.70.36
0.73-0.61-0.120.490.330.190.34-0.2-0.09-0.340.31-0.360.45-0.65-0.22-0.14-0.230.01-0.89
0.870.030.280.980.580.530.1-0.47-0.28-0.610.84-0.070.45-0.21-0.380.33-0.45-0.42-0.42
-0.570.890.63-0.13-0.26-0.17-0.58-0.12-0.250.030.040.7-0.65-0.21-0.050.67-0.05-0.540.82
-0.37-0.36-0.44-0.380.520.570.270.990.970.96-0.330.21-0.22-0.38-0.05-0.431.00.510.2
0.150.640.990.45-0.11-0.09-0.8-0.5-0.47-0.420.310.77-0.140.330.67-0.43-0.45-0.990.21
-0.41-0.39-0.45-0.440.450.50.231.00.960.98-0.420.21-0.23-0.45-0.051.0-0.450.530.19
-0.29-0.54-0.99-0.540.10.10.780.580.510.51-0.34-0.70.01-0.42-0.540.51-0.990.53-0.05
-0.790.790.15-0.44-0.25-0.12-0.190.14-0.010.28-0.070.36-0.89-0.420.820.20.210.19-0.05
Click cells to compare fundamentals

2Seventy Bio Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.